Andrew E Chapman DO FACP
Hematologic Oncology
Director Sidney Kimmel Cancer Center, EVP Oncology Services Jefferson Health System
Join to View Full Profile
833 Chestnut StSte 1140Philadelphia, PA 19107
Phone+1 215-503-3744
Dr. Chapman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Andrew Chapman, DO, is an oncology specialist based in Philadelphia, PA, with a subspecialty in hematologic oncology. He completed his medical education at Kansas City University of Medicine and Biosciences and pursued his residency in Internal Medicine at the University of Pennsylvania Health System, followed by a fellowship in Hematology and Medical Oncology at Temple University Hospital-Fox Chase Cancer Center. As of 2021, he serves as the Director of the Sidney Kimmel Cancer Center at Jefferson Health and has held various roles, including Vice Chair for Clinical Operations at Thomas Jefferson University Hospital since 2014. Dr. Chapman's clinical expertise includes amyloidosis and hematologic oncology. He has published several studies, particularly focused on oncology in older patients. In clinical research, he has been involved in trials exploring treatments for breast cancer and hematologic malignancies. His work has been recognized in various ways, including being consistently named a Philadelphia Top Doctor from 2018 to 2023.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
University of Pennsylvania Health SystemResidency, Internal Medicine, 1988 - 1991
Springfield HospitalInternship, Transitional Year, 1987 - 1988
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1987
Certifications & Licensure
DE State License 2017 - 2027
NJ State License 2017 - 2027
PA State License 1988 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Philadelphia Top Doctor Castle Connelly, 2018-2023
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2017
Clinical Trials
- Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos Start of enrollment: 2011 Jan 01
- Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 Apr 20
- Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Start of enrollment: 2011 Nov 09
Publications & Presentations
PubMed
- 1 citationsOncology Medical Homes: ASCO-Community Oncology Alliance Standards.Kim Woofter, Erin B Kennedy, Kerin Adelson, Ronda Bowman, Andrew E Chapman
JCO Oncology Practice. 2026-03-01 - 1 citationsEvaluation of the Distress Thermometer in older patients with cancer.Charlotte Zuber, Kristine Swartz, Andrew E Chapman, Lora Rhodes, Ting Ting Zhan
Journal of Geriatric Oncology. 2025-05-01 - 10 citationsFunctional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospe...Mina S Sedrak, Can-Lan Sun, Marie Bae, Rachel A Freedman, Allison Magnuson
Journal of Cancer Survivorship. 2024-08-01
Press Mentions
Party with a Purpose Supports Geriatric Oncology ResearchOctober 17th, 2024- Jefferson Health’s Sidney Kimmel Cancer Center Names Vice President for Cancer DisparitiesMarch 18th, 2023
- Thomas Jefferson University Appoints Chair of Medical OncologyJanuary 22nd, 2023
Committees
- Member/Reviewer, ASCO Conquer Cancer Foundation Grant Selection Committee 2023 - Present
- Member, International Society of Geriatric Oncology Publication Committee 2021 - Present
- Member, International Society of Geriatric Oncology Designation Center Working Group 2021 - Present
Professional Memberships
- Member
- Member
- Member
- Member
- International Society of Geriatric Oncology (SIOG)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
